Register to view the archived recording here.
Alnylam Provides Timing for New Pipeline Programs, Inks Two Deals for Biotherapeutics Initiative
After undergoing a makeover of sorts last month when the company unveiled a new product-development strategy, this week it said it remains on track to have five candidates in “advanced” clinical development by 2015.
New to GenomeWeb? Register here quickly.